163 related articles for article (PubMed ID: 12761149)
1. The FimH A27V mutation is pathoadaptive for urovirulence in Escherichia coli B2 phylogenetic group isolates.
Hommais F; Gouriou S; Amorin C; Bui H; Rahimy MC; Picard B; Denamur E
Infect Immun; 2003 Jun; 71(6):3619-22. PubMed ID: 12761149
[TBL] [Abstract][Full Text] [Related]
2. Microevolution in fimH gene of mucosa-associated Escherichia coli strains isolated from pediatric patients with inflammatory bowel disease.
Iebba V; Conte MP; Lepanto MS; Di Nardo G; Santangelo F; Aloi M; Totino V; Checchi MP; Longhi C; Cucchiara S; Schippa S
Infect Immun; 2012 Apr; 80(4):1408-17. PubMed ID: 22290143
[TBL] [Abstract][Full Text] [Related]
3. Differential stability and trade-off effects of pathoadaptive mutations in the Escherichia coli FimH adhesin.
Weissman SJ; Beskhlebnaya V; Chesnokova V; Chattopadhyay S; Stamm WE; Hooton TM; Sokurenko EV
Infect Immun; 2007 Jul; 75(7):3548-55. PubMed ID: 17502398
[TBL] [Abstract][Full Text] [Related]
4. Whole-genome comparison of urinary pathogenic Escherichia coli and faecal isolates of UTI patients and healthy controls.
Nielsen KL; Stegger M; Kiil K; Godfrey PA; Feldgarden M; Lilje B; Andersen PS; Frimodt-Møller N
Int J Med Microbiol; 2017 Dec; 307(8):497-507. PubMed ID: 29031453
[TBL] [Abstract][Full Text] [Related]
5. Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding.
Chen SL; Hung CS; Pinkner JS; Walker JN; Cusumano CK; Li Z; Bouckaert J; Gordon JI; Hultgren SJ
Proc Natl Acad Sci U S A; 2009 Dec; 106(52):22439-44. PubMed ID: 20018753
[TBL] [Abstract][Full Text] [Related]
6. Haplotype diversity in "source-sink" dynamics of Escherichia coli urovirulence.
Chattopadhyay S; Feldgarden M; Weissman SJ; Dykhuizen DE; van Belle G; Sokurenko EV
J Mol Evol; 2007 Feb; 64(2):204-14. PubMed ID: 17177088
[TBL] [Abstract][Full Text] [Related]
7. Selection footprint in the FimH adhesin shows pathoadaptive niche differentiation in Escherichia coli.
Sokurenko EV; Feldgarden M; Trintchina E; Weissman SJ; Avagyan S; Chattopadhyay S; Johnson JR; Dykhuizen DE
Mol Biol Evol; 2004 Jul; 21(7):1373-83. PubMed ID: 15044596
[TBL] [Abstract][Full Text] [Related]
8. Phylogenetic analysis of inflammatory bowel disease associated Escherichia coli and the fimH virulence determinant.
Sepehri S; Kotlowski R; Bernstein CN; Krause DO
Inflamm Bowel Dis; 2009 Nov; 15(11):1737-45. PubMed ID: 19462430
[TBL] [Abstract][Full Text] [Related]
9. Incidence of multidrug resistance, pathogenicity island markers, and pathoadaptive FimH mutations in uropathogenic Escherichia coli isolated from asymptomatic hospitalized patients.
Ghosh A; Mukherjee M
Folia Microbiol (Praha); 2019 Jul; 64(4):587-600. PubMed ID: 30835050
[TBL] [Abstract][Full Text] [Related]
10. Clonal analysis reveals high rate of structural mutations in fimbrial adhesins of extraintestinal pathogenic Escherichia coli.
Weissman SJ; Chattopadhyay S; Aprikian P; Obata-Yasuoka M; Yarova-Yarovaya Y; Stapleton A; Ba-Thein W; Dykhuizen D; Johnson JR; Sokurenko EV
Mol Microbiol; 2006 Feb; 59(3):975-88. PubMed ID: 16420365
[TBL] [Abstract][Full Text] [Related]
11. Genotypic analyses of uropathogenic Escherichia coli based on fimH single nucleotide polymorphisms (SNPs).
Tartof SY; Solberg OD; Riley LW
J Med Microbiol; 2007 Oct; 56(Pt 10):1363-1369. PubMed ID: 17893175
[TBL] [Abstract][Full Text] [Related]
12. Escherichia coli strains belonging to phylogenetic group B2 have superior capacity to persist in the intestinal microflora of infants.
Nowrouzian FL; Wold AE; Adlerberth I
J Infect Dis; 2005 Apr; 191(7):1078-83. PubMed ID: 15747243
[TBL] [Abstract][Full Text] [Related]
13. [Molecular analysis of uropathogenic strains of Escherichia coli and the clinical course of urinary tract infection in children].
Rytlewska M; Liberek A; Sikorska-Wisniewska G; Zalewska B; Kurlenda J; Korzon M
Med Wieku Rozwoj; 2005; 9(4):727-39. PubMed ID: 16733281
[TBL] [Abstract][Full Text] [Related]
14. Escherichia coli ST131-
Liu CM; Stegger M; Aziz M; Johnson TJ; Waits K; Nordstrom L; Gauld L; Weaver B; Rolland D; Statham S; Horwinski J; Sariya S; Davis GS; Sokurenko E; Keim P; Johnson JR; Price LB
mBio; 2018 Aug; 9(4):. PubMed ID: 30154256
[No Abstract] [Full Text] [Related]
15. Role of homologous recombination in adaptive diversification of extraintestinal Escherichia coli.
Paul S; Linardopoulou EV; Billig M; Tchesnokova V; Price LB; Johnson JR; Chattopadhyay S; Sokurenko EV
J Bacteriol; 2013 Jan; 195(2):231-42. PubMed ID: 23123908
[TBL] [Abstract][Full Text] [Related]
16. Virulence genes and phylogenetic groups of uropathogenic Escherichia coli isolates from patients with urinary tract infection and uninfected control subjects: a case-control study.
Rezatofighi SE; Mirzarazi M; Salehi M
BMC Infect Dis; 2021 Apr; 21(1):361. PubMed ID: 33865334
[TBL] [Abstract][Full Text] [Related]
17. Genetic relatedness of the Escherichia coli fecal population and strains causing urinary tract infection in the same host.
Bahadori M; Motamedifar M; Derakhshandeh A; Firouzi R; Motamedi Boroojeni A; Alinejad M; Naziri Z
Microbiologyopen; 2019 Jun; 8(6):e00759. PubMed ID: 30358940
[TBL] [Abstract][Full Text] [Related]
18. Use of fimH single-nucleotide polymorphisms for strain typing of clinical isolates of Escherichia coli for epidemiologic investigation.
Dias RC; Moreira BM; Riley LW
J Clin Microbiol; 2010 Feb; 48(2):483-8. PubMed ID: 20018817
[TBL] [Abstract][Full Text] [Related]
19. Virulence factors of septicemic Escherichia coli strains.
Mokady D; Gophna U; Ron EZ
Int J Med Microbiol; 2005 Oct; 295(6-7):455-62. PubMed ID: 16238019
[TBL] [Abstract][Full Text] [Related]
20. Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000-2001.
Johnson JR; Kuskowski MA; Gajewski A; Sahm DF; Karlowsky JA
J Infect Dis; 2004 Nov; 190(10):1739-44. PubMed ID: 15499527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
